Hot News: Affimed N.V. (NASDAQ:AFMD), Conns Inc. (NASDAQ:CONN), E-Commerce China Dangdang Inc. (NYSE:DANG), Tobira Therapeutics, Inc. (NASDAQ:TBRA), First Bancorp (NASDAQ:FBNC)

Affimed N.V. (NASDAQ:AFMD) belongs to Healthcare sector. Its weekly performance is 10.78%. On last trading day company shares ended up $16.03. Affimed N.V. (NASDAQ:AFMD) distance from 50-day simple moving average (SMA50) is 49.74%. On June 30, Affimed N.V. (NASDAQ:AFMD), announced that the Company has been added to the Russell 2000® index as part of Russell Investments’ quarterly addition of select initial public offering (IPO) companies. Affimed joined the index after the NASDAQ market closed on June 26, 2015.

Conns Inc. (NASDAQ:CONN) shares moved down -4.19% in last trading session and ended the day at $40.75. CONN Gross Margin is 51.30% and its return on assets is 2.90%. Conns Inc. (NASDAQ:CONN) quarterly performance is 26.71%. Conn’s, Inc. (NASDAQ:CONN) reported $102.6 million in total retail net sales for the month ended June 30, 2015, an 11.9% increase compared to the same prior year period. Same store sales for the month increased 1.1%. Conn’s said its same store sales were impacted by the decision to exit video game products, digital cameras, and certain tablets. Excluding the impact from these products, same store sales increased 5.1% during the period.

On 09 July, E-Commerce China Dangdang Inc. (NYSE:DANG) shares moved up 3.99% and was closed at $6.77. E-Commerce China Dangdang Inc. (NYSE:DANG) year to date (YTD) performance is -27.13%. E-Commerce China Dangdang Inc. (NYSE:DANG) announced that that its Board of Directors (the “Board”) has received a non-binding proposal letter, dated July 9, 2015, from Ms. Peggy Yu Yu, Chairwoman of the Board, and Mr. Guoqing Li, director and Chief Executive Officer of the Company (together, the “Buyer Group”), proposing a “going-private” transaction (the “Transaction”) to acquire all of the outstanding ordinary shares of the Company not already beneficially owned by the Buyer Group for $7.812 in cash per American depositary share (“ADS”), each representing five common shares. The proposed purchase price represents a premium of 20% to the closing trading price of the Company’s ADS on July 8th, 2015, the last trading day prior to the date hereof.

Tobira Therapeutics, Inc. (NASDAQ:TBRA) ended the last trading day at $16.52. Company weekly volatility is calculated as 7.11% and price to cash ratio as 6.47. Tobira Therapeutics, Inc. (NASDAQ:TBRA) showed a weekly performance of -1.78%.

First Bancorp (NASDAQ:FBNC) shares moved up 1.15% in last trading session and ended the day at $16.74. FBNC return on assets is 0.80%. First Bancorp (NASDAQ:FBNC) quarterly performance is -3.17%. The Board of Directors of First Bancorp (NASDAQ:FBNC), the parent company of First Bank, has declared a cash dividend on its common stock of $0.08 per share payable July 24, 2015 to shareholders of record as of June 30, 2015. The $0.08 per share dividend rate is the same as the rate declared in the comparable period of 2014.

Leave a Reply

Your email address will not be published. Required fields are marked *